How does the Clinician Evaluate the Atherosclerotic Plaque Quantitatively?

  • J. Bonnet
  • D. Benchimol
Part of the Nato ASI Series book series (NSSA, volume 219)


The human atherosclerotic plaque, unlike some of the experimental models, can be associated with complications such as thrombotic or embolic processes, fissuration, intraplaque haemorrhage, and spasm. The evolution, risk factors, and complication rates vary depending on the arterial segment and affected organs. The problem of detection and quantification of the atherosclerotic disease is in fact linked to the specific atherosclerotic target. The problem for peripheral arteries is different from that for coronary arteries. Therefore the quantitative approaches, as well as the social and medical care implications of studies of the severity of atherosclerosis are different. The high prevalance of ischemic heart disease led us to study problems associated with the detection of the severity of the atherosclerotic process in coronary arteries.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    M. A. De Wood, J. Spores, R. Notske, L. T. Mouser, R. Burroughs, M. S. Golden, and H. T. Lang, Prevalence of total coronary occulusion during the early hours of transmuralmyocardial infarction, N. Engl. J. Med. 303:897 (1980).CrossRefGoogle Scholar
  2. 2.
    K. Gotok, T. Minamion, O. Katoh, Y. Hamano, S. Fuki. The role of intracoronary thrombus in unstable angina: angiographic assessment and thrombolytic therapy during ongoing anginal attack. Circulation 77:526 (1988).CrossRefGoogle Scholar
  3. 3.
    V. Purster, R. L. Prye, D. C. Connolly, M. A. Danielson, L. R. Elveback, and L. T. Kurland, Arteriographic patterns early in the onset of the coronary syndromes, Brit. Heart J. 37:1250 (1975).CrossRefGoogle Scholar
  4. 4.
    A. Moise, J. Lesperance, P. Théroux, Y. Taeymans, C. Goubet, and M. Bourassa, Clinical and angiographic predictors of new total coronary occlusion in coronary artery disease: analyses of 313 nonoperated patients. Am. J. Cardiol. 54:1176 (1984).CrossRefGoogle Scholar
  5. 5.
    V. Porstermann, A. Mugge, V. Alheid, A. Haverich, and J. C. Prolich, Selective attenuation of endothelium-mediated vasodilation in atherosclerotic human coronary arteries, Circ. Res. 62:185 (1988).CrossRefGoogle Scholar
  6. 6.
    K. P. Hossack, B. G. Brown, D. K. Stewart, and H. T. Dodge. Diltiazem-induced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans. Circulation 70:465 (1984).CrossRefGoogle Scholar
  7. 7.
    M. E. Sanmarco, S. H. Brooks, and D. H. Blankenborn, Reproducibility of a consensus panel in the interpretation of coronary angiograms. Am. Heart J. 96:430 (1978).CrossRefGoogle Scholar
  8. 8.
    T. A. De Rouen, J. A. Murray, and W. Owen. Variability in the analysis of coronary angiograms. Circulation 55:324 (1977).CrossRefGoogle Scholar
  9. 9.
    A. C. Thomas, M. J. Davies, S. Dilly, N. Dilly, and P. Pranc, Potential errors in the estimation of coronary arterial stenosis from clinical arteriography with reference to the shape of the coronary arterial lumen, Brit. Heart J. 55:129 (1986).CrossRefGoogle Scholar
  10. 10.
    A. B. Nichols, C. P. O. Babrieli, J. J. Penoglio Jr., and P. D. Esser, Quantification of relative coronary arterial stenosis by cinevideodensitometric analysis of coronary arteriograms, Circulation 69:512 (1984).CrossRefGoogle Scholar
  11. 11.
    S. Ellis, W. Sanders, C. Goubet, R. Miller, K. Cain, J. Lesperance, M. Bourassa, and E. Alderman. Optimal detection of the progression of coronary artery disease: comparison of methods suitable for risk factors intervention trials, Circulation 74:1235 (1986).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • J. Bonnet
    • 1
  • D. Benchimol
    • 1
  1. 1.Department of CardiologyUniversity of BordeauxBordeauxFrance

Personalised recommendations